NCT01803022View on ClinicalTrials.gov

Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer

CompletedOBSERVATIONAL

Enrollment

419

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions

Venous Thromboembolism

Trial Locations (1)

75010

Hopital Saint Louis, Paris

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY

NCT01803022 - Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer | Biotech Hunter | Biotech Hunter